Postmenopausal Alopecia Due to Ovarian Hyperandrogenemia Treated With Bilateral Salpingo-Oophorectomy

January 2020 in “ Journal of South Asian Federation of Obstetrics and Gynaecology ”

Santanu Acharya, Srirupa Chakravorty, DAVID W. RAE

postmenopausal alopecia ovarian hyperandrogenemia male-pattern baldness elevated testosterone GnRH analog bilateral salpingo-oophorectomy androgen levels ovarian hyperandrogenism hair loss testosterone GnRH analogs ovary removal

TLDR Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

A 65-year-old postmenopausal woman experienced male-pattern baldness due to ovarian hyperandrogenemia, confirmed by elevated testosterone levels of ovarian origin using a GnRH analog. Treatment with laparoscopic bilateral salpingo-oophorectomy successfully reduced her androgen levels and partially reversed her hair loss over a year. This case demonstrated the effectiveness of using GnRH analogs for diagnosis and surgical removal of the ovaries in managing alopecia caused by ovarian hyperandrogenism.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

378 citations , November 2011 in “Human reproduction update”

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

research How Should Postmenopausal Androgen Excess Be Evaluated?

63 citations , March 2011 in “Clinical Endocrinology”

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

815 citations , April 2010 in “The Journal of Clinical Endocrinology & Metabolism”

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Related Community Posts Join

6 / 34 results

community Losing Hair on Dutasteride? You might have LPP

in Research/Science 99 upvotes 8 months ago

Men with hair loss might have lichen planopilaris (LPP), which can mimic androgenetic alopecia, leading to misdiagnosis and ineffective treatment with finasteride or dutasteride. Proper diagnosis, including biopsies, is crucial to distinguish between androgenetic alopecia and conditions like LPP.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 1 year ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Dutasteride Isn't Working? Get a Scalp Biopsy NOW

in Finasteride/Dutasteride 19 upvotes 9 months ago

Dutasteride may not be effective for everyone due to underlying issues, suggesting scalp biopsies for further diagnosis. Users discuss using higher doses of dutasteride, topical treatments, minoxidil, and pyrilutamide for hair loss management.

community 24 y/o woman diagnosed with AGA today. Scared and confused.

10 upvotes 9 years ago

A 24-year-old woman being diagnosed with androgenic alopecia (AGA) who is scared and confused about her hair loss, and the treatment options of Minoxidil, finasteride, RU58841, spironolactone, and possibly a biopsy.

community IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia

in Research/Science 13 upvotes 1 year ago

IGFBP‐rP1 shows potential for treating androgenic alopecia by influencing hair cycle transitions. Increasing IGF-1 levels may have similar effects to Minoxidil and 5-AR inhibitors in reducing hair loss.

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 865 upvotes 1 year ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

Related Research

1 / 1 results

research Elevated Free Testosterone Levels in Women With Acne

56 citations , October 1983 in “Archives of Dermatology”

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.